http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2871852-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a7ebd2ce5ef7e691bd44c48a88a2bfc
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-103
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0035
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F13-005
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
filingDate 2014-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c26d7a3ca4206d4629e61fa4397e6b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42ec61095c8081bde82a05b2feac5b9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba8bc216b26f6f87ad8ebc2bf83d2cc5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4258ec341c2c5b81318c8752dcb04934
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5868c81de9402b9dfd23596fcc5e0b6e
publicationDate 2021-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2871852-T3
titleOfInvention Manganese-based magnetic resonance contrast agent
abstract A contrast agent for magnetic resonance imaging, the contrast agent comprising a compound of formula (Ia), (Ib), (Ic) or (Id): **(See formula)** or a pharmaceutically acceptable salt of the compound , wherein R1 is selected from the group consisting of unsubstituted alkylene, unsubstituted cycloalkylene, unsubstituted heterocycloalkylene, unsubstituted arylene, unsubstituted heteroarylene, dialkylenarene, and dialkyleneheteroarene, wherein R2 is selected from the group consisting of hydrogen, alkyl , alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, halo, cyano, nitro, hydroxy, and alkoxy, wherein n is 2 or 3, and wherein the compound optionally includes Mn-coordinated water when n is 2.
priorityDate 2013-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466568259
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467766874
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466848329
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467817016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466639971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466350055

Total number of triples: 33.